Related references
Note: Only part of the references are listed.Safety of third trimester immunization with a respiratory syncytial virus F protein vaccine and protection of infants over the first 180 days of life against all-cause lower respiratory tract infection
G.K. Swamy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)
RSV prevention in infancy and asthma in later life
Nienke M. Scheltema et al.
LANCET RESPIRATORY MEDICINE (2018)
Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery
Karin Stenberg et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2018)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi et al.
LANCET (2017)
Maternal Immunization
Saad B. Omer
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Estimating the full public health value of vaccination
Bradford D. Gessner et al.
VACCINE (2017)
Potential impact of a maternal vaccine for RSV: A mathematical modelling study
Alexandra B. Hogan et al.
VACCINE (2017)
Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England
Deborah Cromer et al.
LANCET PUBLIC HEALTH (2017)
Cost-effectiveness thresholds: pros and cons
Melanie Y. Bertram et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2016)
Stillbirths: rates, risk factors, and acceleration towards 2030
Joy E. Lawn et al.
LANCET (2016)
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015
Kayvon Modjarrad et al.
VACCINE (2016)
Cost of management of severe pneumonia in young children: systematic analysis
Shanshan Zhang et al.
JOURNAL OF GLOBAL HEALTH (2016)
Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings
Piero Poletti et al.
BMC MEDICINE (2015)
Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding
P. K. Munywoki et al.
EPIDEMIOLOGY AND INFECTION (2015)
Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting
Timothy M. Kinyanjui et al.
PLOS ONE (2015)
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
Michael T. Brady et al.
PEDIATRICS (2014)
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
Joshua A. Salomon et al.
LANCET (2012)
Incidence of Respiratory Virus-Associated Pneumonia in Urban Poor Young Children of Dhaka, Bangladesh, 2009-2011
Nusrat Homaira et al.
PLOS ONE (2012)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi district, Kenya
D. James Nokes et al.
CLINICAL INFECTIOUS DISEASES (2008)
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Sue J. Goldie et al.
VACCINE (2008)
Economic evaluations of hepatitis B immunization: A global review of recent studies (1994-2000)
P Beutels
HEALTH ECONOMICS (2001)
Share Paper
